Concepedia

Bolormaa Baljinnyam

BB

19

Publications

1.3K

Citations

16

H-Index

2009

Active since

Affiliations

National Institutes of Health(Current)

National Center for Advancing Translational Sciences

National Cancer Institute

Center for Cancer Research

Johns Hopkins Medicine

Bolormaa Baljinnyam is an author at National Institutes of Health specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2009–2023

19

Publications

19

Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses

Jesse M. Jaynes, Rushikesh Sable, Michael Ronzetti et al. · Science Translational Medicine · 2020 · 401 citations · Full text

Systematic Mapping of WNT-FZD Protein Interactions Reveals Functional Selectivity by Distinct WNT-FZD Pairs

Jacomijn P. Dijksterhuis, Bolormaa Baljinnyam, Karen Stanger et al. · Journal of Biological Chemistry · 2015 · 182 citations · Full text

An OpenData portal to share COVID-19 drug repurposing data in real time

Kyle R. Brimacombe, Tongan Zhao, Richard T. Eastman et al. · 2020 · 106 citations · Full text

, , +25

Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signaling

Charles P. Xavier, Maria Melikova, Yoshiro Chuman et al. · Cellular Signalling · 2013 · 94 citations · Full text

, , +6

Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity

Shyh‐Ming Yang, Natalia J. Martinez, Adam Yasgar et al. · Journal of Medicinal Chemistry · 2018 · 87 citations · Full text

, , +15

Rows per page

1–5 of 19